On this site you will find clinical studies with cannabis or single
cannabinoids in different diseases and case reports on the use of cannabis by
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.
|Title||Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.|
|Author(s)||Flachenecker P, Henze T, Zettl UK.|
|Journal, Volume, Issue||Eur Neurol 2014;71(5-6):271-9.|
|Major outcome(s)||The cannabis extract Sativex provided relief in 74.6% of participants.|
BACKGROUND: Nabiximols (Sativex®), a cannabinoid-based oromucosal spray, is an add-on therapy for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The primary objective was to provide real-life observational data of clinical experience of nabiximols in contrast to formal clinical trials of effectiveness.
|Participants||276 patients with multiple sclerosis|
|Type of publication||Medical journal|
|Address of author(s)||Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany.|